US approves use of landmark pancreatic cancer drug that’s shown to boost survival
Drug blocks key mutated protein driving over 90% of cases in deadly cancer; patients taking pill live median of 13.2 months compared with 6.7 months for patients on chemo
The post https://www.timesofisrael.com/us-approves-use-of-landmark-pancreatic-cancer-drug-thats-shown-to-boost-survival/">US approves use of landmark pancreatic cancer drug that’s shown to boost survival appeared first on https://www.timesofisrael.com">The Times of Israel.